Oncologix Retains The Eversull Group
15 January 2014 - 1:00AM
Marketwired
Oncologix Retains The Eversull Group
ALEXANDRIA, LA--(Marketwired - Jan 14, 2014) - Oncologix Tech
Inc. (OTCQB: OCLG) announced today that it has retained The
Eversull Group to manage its Financial Public Relations, Investor
Relations and Shareholder Consulting Services.
The Eversull Group was established in 1997 and is based in
Frisco, Texas, a suburb of Dallas. The Eversull Group has been
successful in obtaining national and international media coverage
for its public clients and in introducing individual and
institutional investors. The Eversull Group has also been
successful in assisting OTC companies seeking to list on primary
stock exchanges.
Wayne Erwin, Chairman and CEO of Oncologix, stated, "The
Eversull Group is a highly regarded public relations firm with deep
experience in providing information and communications to public
shareholders and potential investors. As we deliver on the
OCLG strategy this year, we will need their high-caliber
organization to assist in disseminating our corporate information
as it occurs. We look forward to their efforts in helping us
grow."
Jack Eversull, President of The Eversull Group, remarked,
"Oncologix fits with our criteria for new clients. They have good
management, strategy, products, services and increasing revenues.
Their strategy to grow via acquisitions that provide healthcare
services is a winner and are a job creator! The Eversull Group
looks forward to providing our services to OCLG and working with
their management."
Oncologix operates and manufactures Class II medical device
products and delivers Personal Healthcare Services nationally. For
its clients, Oncologix provides FDA approved medical devices and
State licensed healthcare services. For its shareholders, Oncologix
operates profitable business divisions that build, maintain and
nourish shareholder value. The Company's corporate mission is to be
the best small cap medical device and healthcare services holding
company in North America.
This press release may contain forward-looking statements, made
in reliance upon Section 21D of the Exchange Act of 1934, which
involve known and unknown risks, uncertainties or other factors
that could cause actual results to differ materially from the
results, performance, or expectations implied by these
forward-looking statements. The Company's expectations, among other
things, are dependent upon economic conditions, continued demand
for its products, the availability of raw materials, retention of
its key management and operating personnel, its ability to operate
its subsidiary companies effectively, need for and availability of
more capital as well as other uncontrollable or unknown factors
which are more fully disclosed in the Company's filings with the
Securities and Exchange Commission.
CONTACT
INFORMATION Wayne Erwin Chairman and CEO Email Contact (318)
769-1958 INVESTOR
RELATIONS Jack Eversull President The Eversull Group, Inc.
972-571-1624 214-469-2361 fax Email Contact
Oncologix Tech (CE) (USOTC:OCLG)
Historical Stock Chart
From Nov 2024 to Dec 2024
Oncologix Tech (CE) (USOTC:OCLG)
Historical Stock Chart
From Dec 2023 to Dec 2024
